REVA Medical, Inc.

Investor Relations

Corporate Profile

REVA Medical, Inc. ("REVA" or the "Company") is a medical device company that has developed a proprietary bioresorbable scaffold, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents...more »

 

Read More

Recent News


Appendix 3B
REVA Medical Reports Third Quarter 2017 Financial Results
REVA Medical Reports Third Quarter 2017 Financial Results
View all

Events


Nov 9, 2017 at 10:00 AM ET
Medical Technologies & Diagnostics Forum
Nov 7, 2017 at 2:00 PM PT
REVA Medical 2017 Third Quarter Update Call
Oct 31, 2017
REVA Presentations at TCT 2017 Conference
View all



Featured Documents


Proxy Statement for 2017 AGM_ASX.pdf Prospectus for Offering of Convertible Notes and Options 2016 Annual Report

Recent Media Covering


REVA's Disappearing Stent to Sell in Europe article from San Diego Business Journal April 2017 (pdf) Executive Series Interview with REVA's CEO Regina Groves May 2017 (video) Clearing the Way article from San Diego Business Journal April 2016 (pdf)


Email Alerts


Sign up to receive the latest financial news and events by email.

Sign up for alerts



Shareholder Tools


Print Print Page
Email Email
ShareShare This
Briefcase Shareholder Briefcase
Printed MaterialsPrinted Materials
Email Alerts Email Alerts
Download CenterDownload Library
snapshotSnapshot
RSSRSS News Feeds